- Isaac Batley, an experienced CEO with 35 years’ experience within healthcare and pharmaceutical communications, joins Uniphar to spearhead its medical communications division
Uniphar, a leading global partner to pharmaceutical and medtech manufacturers, announces the appointment of Isaac Batley as Global Head of Medical and Scientific Communications. In this pivotal role, Isaac will lead the growth of Uniphar’s medical communications capabilities, harnessing his 35 years of leadership experience working in healthcare communications within the pharmaceutical sector.
Isaac’s career includes serving as Chief Executive Officer at SCIRIS where he scaled the medical communications division globally, and heading-up the European Leadership Team at Cello Health before becoming Chairman of the communications agency. Prior to this, Isaac built and sold his own medical communications agency and held a Director-level role at Quintiles working specifically in clinical trials for the NHS.
Isaac spent the first part of his career working with AstraZeneca, Sanofi and Pfizer and his experience and expertise positions him to advance Uniphar’s medical communications, focusing on integrating scientific insights to benefit healthcare professionals, patients, and stakeholders.
Isaac will collaborate closely with key leaders across Uniphar, including Director of Medical Affairs, Maurice Leonard, Managing Director of Access, Dan Piggot, and Managing Director of Commercial, Karl Hamer, to ensure an integrated approach and cohesive medical communications strategy.
Commenting on his appointment, Isaac said: “Medical communications is the unifying thread that ties together the extensive service areas and capabilities that Uniphar has to offer. It touches every aspect of the organization and presents an exciting opportunity to bring these capabilities together in a way that delivers impactful and meaningful results. My remit will cover the whole organization, working to integrate and present Uniphar’s expertise in new and innovative ways.”
The appointment reinforces Uniphar’s ongoing commitment to bringing complex medicines to complex markets, and ensuring an expert team of industry leaders to deliver specialist services to more than 200 international clients across 180 countries.
“Isaac brings a unique perspective and extensive experience that aligns with our mission to transform patient access to medicines. As Uniphar continues to scale globally, Isaac’s leadership and strategic vision will be instrumental in supporting our continued development and growth,” says Brian O’Shaughnessy, Chief Commercial Officer at Uniphar.
For more information on Uniphar, visit www.Uniphar.com/Pharma
Read our Latest News Here
